Bank of Montreal increased its stake in AstraZeneca shares and filed the disclosure with the SEC.
2 reports, 2 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of Montreal increased its stake in AstraZeneca shares and filed the disclosure with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.TD Cowen reiterated a sell rating on AstraZeneca shares following Bank of Montreal's stake increase.1 source
BofM increased its stake in AstraZeneca and filed the required disclosure with the SEC.1 source
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Bank of Montreal
Canadian investment bank
- Insider trading activities reported on September 28, 2026, include a Chair acquiring shares of BCE Inc., a Chief Risk Officer selling BMO shares, and a CEO purchasing Altus Group Ltd. shares.
- BMO manages an ETF listed on the TSX that invests in U.S. large cap equity under Canadian securities legislation.
Related events
- Bank of Montreal increased its holdings by 1.1% in Q4 of i-80 Gold, while a director sold shares and the stock price rose to $1.76.
- Bank of Montreal, Nykredit A S, CPP Investment Board, and Norges Bank all purchased new stakes in a company's stock.
- Norges Bank purchased a new position in Mondelez shares, while Bank of Montreal raised its holdings and First American Bank trimmed its stake.
- Bank of Montreal increased its holdings in Strategic Education Inc. stock and filed the required disclosure with the Securities and Exchange Commission.